BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2005
View Archived Issues
S-23521, a novel GLP-1 analogue, prevents progression of diet-induced diabetes in an animal model
Read More
Clinical evidence supports the use of oral paricalcitol in SHPT
Read More
NXY-059 in acute ischemic stroke: first results of the SAINT I study
Read More
Enrollment completed in dose dense Abraxane study in adjuvant breast cancer
Read More
Conforma's Series C financing to fund development of Hsp90 inhibitors
Read More
Sorafenib accepted into Pilot 1 Program
Read More
Noxxon Pharma demonstrates in vivo efficacy of Spiegelmers in cancer
Read More
VioQuest to acquire Greenwich Therapeutics
Read More
Acorda reaches SPA agreement on Fampridine-SR phase III study in MS
Read More
Genentech IND cleared for phase I trial in basal cell carcinoma
Read More
BioMarin licenses further 6R-BH4 rights from Daiichi Suntory
Read More
Orphan drug designation for arimoclomol for ALS
Read More
SB-509 enters new phase I trial for diabetic neuropathy
Read More
Novel IGF-IR inhibitor synthesized
Read More
Milestones in Rigel and Daiichi collaboration
Read More
Cytochroma secures financing
Read More
Novel analgesic agents imparted by Neurogen, Euroceltique and Merz
Read More
Strong anticancer activity of novel MetAP2 inhibitors
Read More
Full enrollment reached in phase III ACCLAIM chronic heart failure trial
Read More
TL-310: a possible clinical candidate for cancer / News in Context
Read More
Novel agents for arthritis and other inflammatory disorders
Read More
Encouraging results with twice-daily avanafil
Read More
Schering-Plough discloses new therapeutic agents for erectile dysfunction
Read More
GSK discloses novel agents for renal and cardiovascular disorders and cancer
Read More
Rostaporfin prevents visual loss in wet AMD patients with occult CNV lesions
Read More
Update on the efficacy of ezetimibe plus statin therapy in hypercholesterolemia
Read More
Ornidazole prevents postoperative Crohn's disease recurrence
Read More
Telmisartan safe, effective in chronic kidney disease patients
Read More